This inventor holds 2 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Marc Sonveaux
Introduction
Marc Sonveaux is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of vaccines, particularly in the development of inactivated polio vaccines. With a total of 2 patents, Sonveaux's work has the potential to impact public health positively.
Latest Patents
Sonveaux's latest patents focus on inactivated polio vaccines. The present invention relates to vaccines designed to protect against polio, as well as combination vaccines that also guard against diphtheria, tetanus, and pertussis diseases. Specifically, these vaccines comprise reduced doses of inactivated poliovirus, which can maintain adequate or improved levels of protection against polio. The standard dose of polio vaccines typically contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigen units of inactivated poliovirus type 3 (Saukett). Sonveaux's invention demonstrates that reduced doses can still provide effective protection.
Career Highlights
Throughout his career, Sonveaux has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with GlaxoSmithKline Biologicals SA and Prayon. His experience in these organizations has contributed to his expertise in vaccine development.
Collaborations
Sonveaux has collaborated with several professionals in his field, including Michel Duchene and Herve De Hemptinne. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Marc Sonveaux's contributions to vaccine development, particularly in the area of inactivated polio vaccines, highlight his role as an influential inventor. His work not only showcases his innovative spirit but also emphasizes the importance of advancements in public health.